Emcure Pharma IPO Lists At 30% Premium | Namita Thapar & Satish Mehta Share Details | Business News

The Emcure Pharma IPO has made a remarkable debut in the stock market, listing at a significant premium of 30%. This successful initial public offering has garnered attention from investors and industry experts alike. In an exclusive interview, Namita Thapar and Satish Mehta share insightful details about the IPO. This news update provides valuable information for individuals interested in the business world, particularly in the pharmaceutical sector.
#emcurepharma #emcurepharmaipo #ipolauch #etnow #unionbudget2024 #budget2024 #topnews #stockmarket #businessnews #sharemarketnews
Subscribe To ET Now For Latest Updates On Stocks, share market, business News, Trading, Crypto Updates | bit.ly/Subscri...
To Stay Updated Download the Times Now App :-
Android Google Play : goo.gl/zJhWjC
Apple App Store : goo.gl/d7QBQZ
Social Media Links :-
Twitter - goo.gl/hA0vDt
Facebook - goo.gl/5Lr4mC
G+ - goo.gl/hYxrmj
Website - www.etnownews.com
Subscribe Now To Our Network Channels:-
Times Now: bit.ly/Subscri...
Mirror Now: bit.ly/Subscri...